Miranda Luana Aparecida, Luvizutto Gustavo José, Bessornia Pedro Augusto Cândido, Furlan Natalia Eduarda, Winckler Fernanda Cristina, Ferreira Natalia Cristina, Hamamoto Filho Pedro Tadao, de Souza Juli Thomaz, Martin Luis Cuadrado, Zanati Bazan Silméia Garcia, Pinheiro Modolo Gabriel, de Freitas Carlos Clayton Macedo, Vidal Edison Iglesias de Oliveira, Bazan Rodrigo
Department of Neurology, Psychology, and Psychiatry, Botucatu Medical School, São Paulo State University, Botucatu, São Paulo, Brazil.
Department of Applied Physical Therapy, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
Front Aging Neurosci. 2024 Jan 25;16:1305803. doi: 10.3389/fnagi.2024.1305803. eCollection 2024.
We evaluated the extent to which frailty mediated the association between age, poor functional outcomes, and mortality after acute ischemic stroke when patients were treated with brain reperfusion (thrombolytic therapy and/or thrombectomy).
This retrospective cohort study included patients diagnosed with ischemic stroke who had undergone intravenous cerebral reperfusion therapy and/or mechanical thrombectomy. We created a mediation model by analyzing the direct natural effect of an mRS score > 2 and death on age-mediated frailty according to the Frailty Index.
We enrolled 292 patients with acute ischemic stroke who underwent brain reperfusion. Their mean age was 67.7 ± 13.1 years. Ninety days after the stroke ictus, 54 (18.5%) participants died, and 83 (28.4%) lived with moderate to severe disability (2 < mRS < 6). In the mediation analysis of the composite outcome of disability (mRS score > 2) or death, frailty accounted for 28% of the total effect of age. The models used to test for the interaction between age and frailty did not show statistically significant interactions for either outcome, and the addition of the interaction did not significantly change the direct or indirect effects, nor did it improve model fit.
Frailty mediated almost one-third of the effect of age on the composite outcome of disability or death after acute ischemic stroke.
我们评估了在急性缺血性卒中患者接受脑再灌注治疗(溶栓治疗和/或血栓切除术)时,衰弱在多大程度上介导了年龄、不良功能结局和死亡率之间的关联。
这项回顾性队列研究纳入了诊断为缺血性卒中且接受过静脉脑再灌注治疗和/或机械取栓术的患者。我们根据衰弱指数分析了改良Rankin量表(mRS)评分>2和死亡对年龄介导的衰弱的直接自然效应,从而建立了一个中介模型。
我们纳入了292例接受脑再灌注治疗的急性缺血性卒中患者。他们的平均年龄为67.7±13.1岁。卒中发作90天后,54例(18.5%)参与者死亡,83例(28.4%)有中度至重度残疾(2<mRS<6)。在对残疾(mRS评分>2)或死亡的综合结局进行中介分析时,衰弱占年龄总效应的28%。用于检验年龄与衰弱之间相互作用的模型,对于任何一个结局均未显示出具有统计学意义的相互作用,并且加入相互作用项并未显著改变直接效应或间接效应,也未改善模型拟合度。
衰弱介导了年龄对急性缺血性卒中后残疾或死亡综合结局近三分之一的影响。